SecuringPharma - Pharmaceutical anti-counterfeiting news

News headlines:

Manage subscription Reset Password

3rd Annual Packaging and Labelling Congress

Don't let counterfeits distract from substandard drugs, says think tank

The dangers of substandard medicines are being ignored and policymakers must do more to ensure that patient safety is maintained, according to the Stockholm Network, a European think tank.

Other News

Rx-360 warns of contamination in pharma chemical
Rx-360 reports that drugmakers are encountering contamination problems with tromethamine and related substances used in manufacturing.
UK pilot shows serialisation and authentication in harmony
A pilot project that demonstrates the potential of pharmaceutical serialisation, tracking and authentication of drugs as they travel through the supply chain has been completed by SecureTrace, a consortium of UK companies.
FDA promises a revamp of its criminal investigations unit
The FDA's unit for investigating counterfeit drugs, contaminated food and other criminal activities is suffering from a lack of oversight and operational review, according to the US government's General Accounting Office.
Green light for Rx-360 audit sharing pilot
The pilot phase of an ambitious scheme aimed at allowing pharmaceutical manufacturers to share audits of suppliers has got underway, according to the Rx-360 consortium behind the project.
Fujifilm launches anti-counterfeit label
Fujifilm has introduced what it claims is the world's first anti-counterfeit label that supports hidden, full-colour images and can be checked using a simple visual device.
PQG unveils 'how to' guide for reducing supply chain risk
A new guide has been developed by the Pharmaceutical Quality Group to help drugmakers and their suppliers identify and manage risk in the supply chain.

News in brief

Cutting out the middleman: the rise of direct distribution in pharma
A new trend in the US pharmaceutical sector, restricted distribution, is providing new opportunities to companies providing technologies that track goods from the manufacturer to the consumer.
Parliamentary report broadens, accelerates counterfeiting directive
The European Parliamentary report on the proposed counterfeit directive is now in circulation, with the author, MEP Marisa Matias, putting forward a number of amendments that widen its scope.
PGEU wants robust debate on safety features
There needs to be a “robust” debate about the type of safety features to be applied under the European Commission’s draft directive on counterfeit medicines, says PGEU chief John Chave.